Close

Covidien Announced FDA Clearance of New LigaSure(TM) Instrument

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

New WHO-Listed Authorities Designated for Quality...

For the first time, the World Health Organization has...

Dynacare, Evexia to Start Health Testing...

Dynacare, which happens to be one of the leading...

China Takes Decision on Medical Device...

China has hit back against certain EU restrictions that...

BD Commits Expanding the Prefilled Flush...

Beckton Dickinson – BD is investing over $35mn in...
Febuary 17th :- Covidien, a leading global provider of healthcare products, announced 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the LigaSure(TM) Curved, Small Jaw, Open Sealer/Divider surgical instrument. The device is indicated for use in general surgery and will be available in the United States this quarter.

The LigaSure Curved, Small Jaw, Open Sealer/Divider, the newest addition to the LigaSure family of advanced surgical cutting/sealing devices, provides an integrated cutting mechanism independent of sealing, leaving the critical cutting decisions in the hands of the surgeon. Its multi-functional design also provides for blunt dissection and an enhanced, more efficient experience for the surgeon, especially in confined surgical spaces. A primary feature of this new LigaSure device is a low-temperature profile and minimal thermal spread to surrounding tissues.

The proven LigaSure technology, powered by the ForceTriadTM energy platform, provides surgeons with a continuous output of energy, monitoring the tissue and making real-time adjustments 3,333 times/second to seal vessel walls. LigaSure technology has been in use for 12 years, and is utilized in more than one million procedures around the world each year.

Latest stories

Related stories

New WHO-Listed Authorities Designated for Quality Assurance

For the first time, the World Health Organization has...

Dynacare, Evexia to Start Health Testing Services in Canada

Dynacare, which happens to be one of the leading...

China Takes Decision on Medical Device Contracts for the EU

China has hit back against certain EU restrictions that...

BD Commits Expanding the Prefilled Flush Syringes in the US

Beckton Dickinson – BD is investing over $35mn in...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back